ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 9 (1) 45 -59     DOI: 10.1677/erc.0.0090045
Copyright © 2002 by the Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (81)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colston, K.
Right arrow Articles by Hansen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colston, K.
Right arrow Articles by Hansen, C.
Endocrine Related Cancer, Vol 9, Issue 1, 45-59
Copyright © 2002 by Society for Endocrinology


Articles

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer

KW Colston and CM Hansen


It is now well established that, in addition to its central role in the maintenance of extracellular calcium levels and bone mineralization, 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), the active form of vitamin D, also acts as a modulator of cell growth and differentiation in a number of cell types, including breast cancer cells. The anti-proliferative effects of 1,25(OH)(2)D(3) have been linked to suppression of growth stimulatory signals and potentiation of growth inhibitory signals, which lead to changes in cell cycle regulators such as p21(WAF-1/CIP1) and p27(kip1), cyclins and retinoblastoma protein as well as induction of apoptosis. Such studies have led to interest in the potential use of 1,25(OH)(2)D(3) in the treatment or prevention of certain cancers. Since this approach is limited by the tendency of 1,25(OH)(2)D(3) to cause hypercalcaemia, synthetic vitamin D analogues have been developed which display separation of the growth regulating effects from calcium mobilizing actions. This review examines mechanisms by which 1,25(OH)(2)D(3) and its active analogues exert both anti-proliferative and pro-apoptotic effects and describes some of the synthetic analogues that have been shown to be of particular interest in relation to breast cancer.


This article has been cited by other articles:


Home page
Anticancer ResHome page
K. KOSTNER, N. DENZER, C. S.L. MULLER, R. KLEIN, W. TILGEN, and J. REICHRATH
The Relevance of Vitamin D Receptor (VDR) Gene Polymorphisms for Cancer: A Review of the Literature
Anticancer Res, September 1, 2009; 29(9): 3511 - 3536.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
D. FISCHER, M. THOME, S. BECKER, T. CORDES, K. DIEDRICH, M. FRIEDRICH, and M. THILL
25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Splice Variants in Benign and Malignant Ovarian Cell Lines and Tissue
Anticancer Res, September 1, 2009; 29(9): 3627 - 3633.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
D. FISCHER, S. BECKER, T. CORDES, B. BUCKER, K. DIEDRICH, M. FRIEDRICH, D. SALEHIN, and M. THILL
Vitamin D-24-Hydroxylase in Benign and Malignant Breast Tissue and Cell Lines
Anticancer Res, September 1, 2009; 29(9): 3641 - 3645.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
M. PETERLIK, W. B. GRANT, and H. S. CROSS
Calcium, Vitamin D and Cancer
Anticancer Res, September 1, 2009; 29(9): 3687 - 3698.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
K. D. Crew, M. D. Gammon, S. E. Steck, D. L. Hershman, S. Cremers, E. Dworakowski, E. Shane, M. B. Terry, M. Desai, S. L. Teitelbaum, et al.
Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk
Cancer Prevention Research, June 1, 2009; 2(6): 598 - 604.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. D. Crew, E. Shane, S. Cremers, D. J. McMahon, D. Irani, and D. L. Hershman
High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy
J. Clin. Oncol., May 1, 2009; 27(13): 2151 - 2156.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Deng, E. Ueda, K. E. Chen, C. Bula, A. W. Norman, R. A. Luben, and A. M. Walker
Prolactin Blocks Nuclear Translocation of VDR by Regulating Its Interaction with BRCA1 in Osteosarcoma Cells
Mol. Endocrinol., February 1, 2009; 23(2): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. McKay, M. L. McCullough, R. G. Ziegler, P. Kraft, B. S. Saltzman, E. Riboli, A. Barricarte, C. D. Berg, G. Bergland, S. Bingham, et al.
Vitamin D Receptor Polymorphisms and Breast Cancer Risk: Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 297 - 305.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
K. McCARTHY, C. LABAN, S. A. BUSTIN, W. OGUNKOLADE, S. KHALAF, R. CARPENTER, and P. J. JENKINS
Expression of 25-Hydroxyvitamin D-1-{alpha}-Hydroxylase, and Vitamin D Receptor mRNA in Normal and Malignant Breast Tissue
Anticancer Res, January 1, 2009; 29(1): 155 - 157.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
K. M. Blackmore, M. Lesosky, H. Barnett, J. M. Raboud, R. Vieth, and J. A. Knight
Vitamin D From Dietary Intake and Sunlight Exposure and the Risk of Hormone-Receptor-Defined Breast Cancer
Am. J. Epidemiol., October 15, 2008; 168(8): 915 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. M. Chlon, D. A. Taffany, J. Welsh, and M. J. Rowling
Retinoids Modulate Expression of the Endocytic Partners Megalin, Cubilin, and Disabled-2 and Uptake of Vitamin D-Binding Protein in Human Mammary Cells
J. Nutr., July 1, 2008; 138(7): 1323 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude
The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1339 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Freedman, S.-C. Chang, R. T. Falk, M. P. Purdue, W.-Y. Huang, C. A. McCarty, B. W. Hollis, B. I. Graubard, C. D. Berg, and R. G. Ziegler
Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude
Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study
Carcinogenesis, January 1, 2008; 29(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. M. John, G. G. Schwartz, J. Koo, W. Wang, and S. A. Ingles
Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population
Am. J. Epidemiol., December 15, 2007; 166(12): 1409 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Wedren, C. Magnusson, K. Humphreys, H. Melhus, A. Kindmark, F. Stiger, M. Branting, I. Persson, J. Baron, and E. Weiderpass
Associations between Androgen and Vitamin D Receptor Microsatellites and Postmenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1775 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Knight, M. Lesosky, H. Barnett, J. M. Raboud, and R. Vieth
Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Knight, C. M. Vachon, R. A. Vierkant, R. Vieth, J. R. Cerhan, and T. A. Sellers
No association between 25-hydroxyvitamin d and mammographic density.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1988 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Cui and T. E. Rohan
Vitamin d, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Diorio, S. Berube, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, M. Pollak, and J. Brisson
Influence of Insulin-like Growth Factors on the Strength of the Relation of Vitamin D and Calcium Intakes to Mammographic Breast Density
Cancer Res., January 1, 2006; 66(1): 588 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Berube, C. Diorio, B. Masse, N. Hebert-Croteau, C. Byrne, G. Cote, M. Pollak, M. Yaffe, and J. Brisson
Vitamin D and Calcium Intakes from Food or Supplements and Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison
Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue
Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. S Calvo, S. J Whiting, and C. N Barton
Vitamin D fortification in the United States and Canada: current status and data needs
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1710S - 1716S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Berube, C. Diorio, W. Verhoek-Oftedahl, and J. Brisson
Vitamin D, Calcium, and Mammographic Breast Densities
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1466 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. G Moorman and P. D Terry
Consumption of dairy products and the risk of breast cancer: a review of the literature
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 5 - 14.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison
Vitamin D and Placental-Decidual Function
Reproductive Sciences, July 1, 2004; 11(5): 263 - 271.
[Abstract] [PDF]


Home page
Cancer Res.Home page
H. G. Palmer, M. Sanchez-Carbayo, P. Ordonez-Moran, M. J. Larriba, C. Cordon-Cardo, and A. Munoz
Genetic Signatures of Differentiation Induced by 1{alpha},25-Dihydroxyvitamin D3 in Human Colon Cancer Cells
Cancer Res., November 15, 2003; 63(22): 7799 - 7806.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Kavanaugh and J. E. Green
The Use of Genetically Altered Mice for Breast Cancer Prevention Studies
J. Nutr., July 1, 2003; 133(7): 2404S - 2409.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. M. El-Mowafy and M. Alkhalaf
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism
Carcinogenesis, May 1, 2003; 24(5): 869 - 873.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.